Skip to content

Clinical trials

Withdrawn Phase 3 Diabetes Mellitus, Type 2 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Status: Withdrawn Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20111
20135
20153
20172
20181
20202
20211
20222
20231
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eurofarma Laboratorios S.A.3
Intarcia Therapeutics3
Novo Nordisk A/S3
Asociación para Evitar la Ceguera en México2
EMS2
GlaxoSmithKline2
Boehringer Ingelheim1
Eli Lilly and Company1
Hoffmann-La Roche1
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 226
Hypertension3
Insulin Resistance2
Renal Insufficiency, Chronic2
Bronchiolitis Obliterans Syndrome1
Cardiovascular Diseases1
Diabetes Complications1
Diabetes Mellitus1
Diabetes Mellitus, Type 11
Diabetic Nephropathies1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.